Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Midazolam

A short-acting benzodiazepine synthesised in the United States in 1975 and in clinical use since 1982: it is used for sedation before medical procedures, in anaesthesia and against prolonged seizures. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.

Did you know?In acidic solution up to 40% of the molecule exists in a water-soluble form with one ring opened: once in the body, the ring closes again, restoring the active, lipophilic form.

MidazolamGo to the active ingredient →
MidazolamActive ingredientMidazolamCat. No. P-M122-001CAS 59467-70-8
Midazolam-d6Isotopically labelledMidazolam-d6Cat. No. P-M122-016CAS 1246819-79-3

EDQM standards 3

The official European Pharmacopoeia standards for this family.

Reference substanceMidazolam CRSEDQM code M2200000Family Midazolam

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.